This 2016 narrative review from Drexel summarizes the pathogenesis, diagnosis, and surgical management of pigmented villonodular synovitis (PVNS). It distinguishes localized from diffuse disease, reviews recurrence data by surgical approach, and proposes a treatment algorithm incorporating emerging CSF1R-targeted therapies.
A young patient with a swollen, painful knee and an ill-defined intra-articular mass on MRI with hemosiderin blooming artifact has PVNS until proven otherwise — get a biopsy, not just a synovial fluid analysis.
Once you have the diagnosis, the form dictates the operation. For localized disease, arthroscopic excision is definitive (~8% recurrence). For diffuse disease, arthroscopy alone is not enough: recurrence hits 92-94% without addressing the posterior compartment through an open approach.
When you see a patient with diffuse PVNS in a technically demanding joint (hip, elbow) or with recurrent disease after prior surgery, consider referral to an orthopedic oncologist or enrollment in a CSF1R inhibitor trial rather than escalating to increasingly morbid open procedures.
The authors explicitly recommend against radiation therapy for this benign condition given the risk of malignant transformation to radiation-induced sarcoma, a particularly important point when treating young adults.
This 2016 narrative review from Drexel summarizes the pathogenesis, diagnosis, and surgical management of pigmented villonodular synovitis (PVNS). It distinguishes localized from diffuse disease, reviews recurrence data by surgical approach, and proposes a treatment algorithm incorporating emerging CSF1R-targeted therapies.
A young patient with a swollen, painful knee and an ill-defined intra-articular mass on MRI with hemosiderin blooming artifact has PVNS until proven otherwise — get a biopsy, not just a synovial fluid analysis.
Once you have the diagnosis, the form dictates the operation. For localized disease, arthroscopic excision is definitive (~8% recurrence). For diffuse disease, arthroscopy alone is not enough: recurrence hits 92-94% without addressing the posterior compartment through an open approach.
When you see a patient with diffuse PVNS in a technically demanding joint (hip, elbow) or with recurrent disease after prior surgery, consider referral to an orthopedic oncologist or enrollment in a CSF1R inhibitor trial rather than escalating to increasingly morbid open procedures.
The authors explicitly recommend against radiation therapy for this benign condition given the risk of malignant transformation to radiation-induced sarcoma, a particularly important point when treating young adults.